Frontiers | Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update
Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms | Published in healthbook TIMES Oncology Hematology
Persistence of LSCs: BCR-ABL1 kinase-dependent and -independent pathways. | Download Scientific Diagram
Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group | Modern Pathology
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? - Chiaretti - 2019 - Cancer - Wiley Online Library
Pharmaceutics | Free Full-Text | BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia | NEJM
IJMS | Free Full-Text | Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Pharmaceutics | Free Full-Text | BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission | Leukemia
Persistence of LSCs: BCR-ABL1 kinase-dependent and -independent pathways. | Download Scientific Diagram
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? - Chiaretti - 2019 - Cancer - Wiley Online Library
Low prevalence of the BCR–ABL1 fusion gene in a normal population in southern Sarawak | SpringerLink
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes - ScienceDirect
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Cancers | Free Full-Text | Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR
The Philadelphia chromosome in leukemogenesis | Cancer Communications | Full Text
Frontiers | Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib? – ScienceOpen
HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia | Leukemia
IVD Antibody Development Services for BCR-ABL Marker - Creative Biolabs
